Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 98.95 INR
Change Today -1.95 / -1.93%
Volume 264.8K
ICP On Other Exchanges
Symbol
Exchange
ICP is not on other exchanges.
As of 7:06 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

iol chemicals and pharma ltd (ICP) Snapshot

Open
102.00
Previous Close
100.90
Day High
102.00
Day Low
98.00
52 Week High
07/21/15 - 113.90
52 Week Low
03/24/15 - 24.00
Market Cap
5.0B
Average Volume 10 Days
333.3K
EPS TTM
-16.72
Shares Outstanding
50.5M
EX-Date
02/28/97
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IOL CHEMICALS AND PHARMA LTD (ICP)

Related News

No related news articles were found.

iol chemicals and pharma ltd (ICP) Related Businessweek News

No Related Businessweek News Found

iol chemicals and pharma ltd (ICP) Details

IOL Chemicals and Pharmaceuticals Limited manufactures and sells industrial organic chemicals and bulk drugs worldwide. It operates through Chemicals and Drugs segments. The Chemicals segment offers ethyl acetate, acetic anhydride, acetyl chloride, mono chloro acetic acid, and Iso butyl benzene chemical products for use in flexible packaging, pharmaceuticals, textiles, food processing, pesticides, and paint industries. The Drugs segment provides various active pharmaceutical ingredients, such as ibuprofen, ibuprofen sodium, dex-ibuprofen, omeprazole, lansoprazole, metformin hydrochloride, lamotrigine, fenofibrate, losartan potassium, desloratadine, fluconazole, clopidogrel bi sulphate, tramadol hydrochloride, telmisartan, olmesartan, hydrochlorothiazide, rosuvastatin calcium, oxcarbazepine, and olanzapine for use in various therapeutic categories, including pain management, anti-diabetic, anti-hypertensive, anti-convulsants, anti-ulcer, anti-cholesterol, anti-histaminic, anti-fungal, anti-platlet, analgesic, and diuretic. The company was founded in 1986 and is headquartered in Ludhiana, India.

Founded in 1986

iol chemicals and pharma ltd (ICP) Top Compensated Officers

Managing Director, Director and Member of Sta...
Total Annual Compensation: 1.9M
Joint Managing Director and Whole Time Direct...
Total Annual Compensation: 1.7M
Director of Works, Director and Member of Sta...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2014.

iol chemicals and pharma ltd (ICP) Key Developments

IOL Chemicals and Pharmaceuticals to Launch API Business to US Market

IOL Chemicals and Pharmaceuticals Ltd. has received from US Food and Drug Administration (USFDA), Establishment Inspection Report after successful inspection of its Ibuprofen manufacturing facility situated at Barnala, Punjab, India. Post this approval, the company will be able to garner additional business for its API Ibuprofen in World's large pharma market-USA. This will result into higher value added export turnover and higher margins. The company’s manufacturing facility already holds CEP certification (Certificate of Suitability) for its products Ibuprofen, Metformin Hydrochloride & Lamotrigine from European Directorate for the Quality of Medicines & HealthCare (EDQM) authorities, Council of Europe, France. The said facility at Barnala has also been approved by ANVISA Brazil, WHO & MOH Japan. These approvals will help the company to build and sustaining the growth by its API business in coming years, being the only integrated player globally, by exploring the higher value added regulated markets.

IOL Chemicals and Pharmaceuticals Ltd., Board Meeting, Jul 03, 2015

IOL Chemicals and Pharmaceuticals Ltd., Board Meeting, Jul 03, 2015. Agenda: To allot 500,000 equity shares of INR 10 each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval.

Iol Chemicals and Pharmaceuticals Ltd. Reports Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

IOL Chemicals and Pharmaceuticals Ltd. Reported audited earnings results for the fourth quarter and year ended March 31, 2015. The company reported total income from operations of INR 752.732 million, loss from operations before other income, finance cost and exceptional items of INR 161.939 million, loss from ordinary activities before tax of INR 309.369 million, net loss of INR 280.555 million or INR 6.97 per diluted share against total income from operations of INR 1,309.877 million, profit from operations before other income, finance cost and exceptional items of INR 159.654 million, profit from ordinary activities before tax of INR 9.779 million, net profit of INR 8.103 million or INR 0.28 per diluted share a year ago. For the year, the company reported total income from operations of INR 3,860.239 million, loss from operations before other income, finance cost and exceptional items of INR 163.506 million, loss from ordinary activities before tax of INR 754.380 million, net loss of INR 666.507 million or INR 16.63 per diluted share against total income from operations of INR 5,647.900 million, profit from operations before other income, finance cost and exceptional items of INR 654.082 million, profit from ordinary activities before tax of INR 50.823 million, net profit of INR 32.994 million or INR 1.21 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICP:IN 98.95 INR -1.95

ICP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ICP.
View Industry Companies
 

Industry Analysis

ICP

Industry Average

Valuation ICP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IOL CHEMICALS AND PHARMA LTD, please visit www.iolcp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.